{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:50:19Z","timestamp":1790092219500,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12350-019-01935-1","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:02:51Z","timestamp":1572969771000},"page":"1464-1468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The current status of quantitative SPECT\/CT in the assessment of transthyretin cardiac amyloidosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Stuart C.","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cuscaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01935-1_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation."},{"key":"10.1007\/s12350-019-01935-1_bib2","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation."},{"key":"10.1007\/s12350-019-01935-1_bib3","doi-asserted-by":"crossref","unstructured":"Cappelli F, Gallini C, Di Mario C, Egidio Natalino Costanzo, Luca Vaggelli, Francesca Tutino, et al. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol 2017. https:\/\/doi.org\/10.1007\/s12350-017-0922-z","DOI":"10.1007\/s12350-017-0922-z"},{"key":"10.1007\/s12350-019-01935-1_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid."},{"key":"10.1007\/s12350-019-01935-1_bib5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","volume":"18","author":"Habib","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib6","unstructured":"Andrikopoulou E, Bhambhvani P. Nuclear imaging of cardiac amyloidosis. J Nucl Cardiol 2017."},{"key":"10.1007\/s12350-019-01935-1_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: A bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib8","doi-asserted-by":"crossref","unstructured":"Rapezzi C, Gagliardi C, Milandri A. Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. J Nucl Cardiol 2018.","DOI":"10.1007\/s12350-018-1235-6"},{"key":"10.1007\/s12350-019-01935-1_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib11","doi-asserted-by":"crossref","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019.","DOI":"10.1016\/j.cardfail.2019.08.001"},{"key":"10.1007\/s12350-019-01935-1_bib12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12350-016-0768-9","article-title":"Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes","volume":"25","author":"Vranian","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000098","article-title":"Senile systemic amyloidosis: Clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"10.1007\/s12350-019-01935-1_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JND-180371","article-title":"Clinical presentation, diagnosis and treatment of TTR amyloidosis","volume":"6","author":"Kapoor","year":"2019","journal-title":"J Neuromuscul Dis."},{"key":"10.1007\/s12350-019-01935-1_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","article-title":"High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: A common cause of carpal tunnel syndrome in the elderly","volume":"42","author":"Sekijima","year":"2011","journal-title":"Hum Pathol."},{"key":"10.1007\/s12350-019-01935-1_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2017.1375908","article-title":"Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: Can we identify affected patients earlier?","volume":"24","author":"Rubin","year":"2017","journal-title":"Amyloid."},{"key":"10.1007\/s12350-019-01935-1_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA."},{"key":"10.1007\/s12350-019-01935-1_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13506129.2018.1520087","article-title":"Quantitation of (99m)Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis","volume":"25","author":"Ross","year":"2018","journal-title":"Amyloid."},{"key":"10.1007\/s12350-019-01935-1_bib19","doi-asserted-by":"crossref","unstructured":"Sperry BW, Gonzalez MH, Brunken R, Cerqueira MD, Hanna M, Jaber WA. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis. J Nucl Cardiol 2018.","DOI":"10.1007\/s12350-017-1166-7"},{"key":"10.1007\/s12350-019-01935-1_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1007\/s12350-019-01935-1_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2017.10.027","article-title":"Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon","volume":"254","author":"Cappelli","year":"2018","journal-title":"Int J Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib22","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.1007\/s12350-019-01935-1_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar Technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib25","unstructured":"Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, et al. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. J Nucl Cardiol 2019."},{"key":"10.1007\/s12350-019-01935-1_bib26","unstructured":"Martineau P, Finnerty V, Giraldeau G, Authier S, Harel F, Pelletier-Galarneau M. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis. J Nucl Cardiol 2019."},{"key":"10.1007\/s12350-019-01935-1_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with (18)F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib28","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s00259-013-2542-4","article-title":"Quantitative SPECT\/CT: SPECT joins PET as a quantitative imaging modality","volume":"41","author":"Bailey","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/MNM.0000000000000586","article-title":"Activity concentration measurements using a conjugate gradient (Siemens xSPECT) reconstruction algorithm in SPECT\/CT","volume":"37","author":"Armstrong","year":"2016","journal-title":"Nucl Med Commun."},{"key":"10.1007\/s12350-019-01935-1_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41824-018-0035-1","article-title":"Tc-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population","volume":"2","author":"Ramsay","year":"2018","journal-title":"Eur J Hybrid Imaging."},{"key":"10.1007\/s12350-019-01935-1_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-019-01935-1_bib32","doi-asserted-by":"crossref","unstructured":"Caobelli F, Braun M, Haaf P, Wild D, Zellweger MJ. Quantitative (99m)Tc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores. J Nucl Cardiol 2019.","DOI":"10.1007\/s12350-019-01893-8"},{"key":"10.1007\/s12350-019-01935-1_bib33","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab2a22","article-title":"Performance evaluation of quantitative SPECT\/CT using NEMA NU 2 PET methodology","volume":"64","author":"Ryu","year":"2019","journal-title":"Phys Med Biol."},{"key":"10.1007\/s12350-019-01935-1_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1007\/s12350-019-01935-1_bib35","first-page":"6","article-title":"Prevalence of transthyretin (ATTR) cardiac amyloidosis in the Australian population estimated using 99mTc-hydroxymethylene diphosphonate planar bone scans","volume":"49","author":"Cuscaden","year":"2019","journal-title":"Int Med J."}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-019-01935-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:37Z","timestamp":1761026857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123020330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1071358123020330"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01935-1","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current status of quantitative SPECT\/CT in the assessment of transthyretin cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01935-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}